APA (7th ed.) Citation

Burris, H. A., Lebrun, F., Rugo, H. S., Beck, J. T., Piccart, M., Neven, P., . . . Noguchi, S. (2013). Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial. Cancer (0008543X), 119(10), 1908. https://doi.org/10.1002/cncr.28010

Chicago Style (17th ed.) Citation

Burris, Howard A., et al. "Health-related Quality of Life of Patients with Advanced Breast Cancer Treated with Everolimus Plus Exemestane Versus Placebo Plus Exemestane in the Phase 3, Randomized, Controlled, BOLERO-2 Trial." Cancer (0008543X) 119, no. 10 (2013): 1908. https://doi.org/10.1002/cncr.28010.

MLA (9th ed.) Citation

Burris, Howard A., et al. "Health-related Quality of Life of Patients with Advanced Breast Cancer Treated with Everolimus Plus Exemestane Versus Placebo Plus Exemestane in the Phase 3, Randomized, Controlled, BOLERO-2 Trial." Cancer (0008543X), vol. 119, no. 10, 2013, p. 1908, https://doi.org/10.1002/cncr.28010.